Archives of Pharmacal Research

, Volume 39, Issue 11, pp 1548–1555 | Cite as

Essential role of interferon regulatory factor 4 (IRF4) in immune cell development

Review

Abstract

The family of interferon regulatory factors, which includes nine mammalian members (IRF1–IRF9), acts as transcription factors for interferons and thus exerts regulatory functions in the immune system and in oncogenesis. Among these members, IRF4 expression is restricted to immune cells such as T and B lymphocytes, macrophages, and dendritic cells where it is a key factor in the regulation of differentiation and is required during the immune response for lymphocyte activation and the generation of immunoglobulin-secreting plasma cells. Consequently, dysregulation of IRF4 is associated with many lymphoid malignancies. Recent studies have demonstrated that depending on the context and stage of hematopoietic cell differentiation in which its expression is dysregulated, IRF4 may act as either an oncogene or a tumor-suppressor-like factor. In addition, it has been shown that IRF4 plays a pivotal role in the development and function of several autoimmune-associated cells. Various genetic and functional studies have also pointed to IRF4 as a master regulator for autoimmunity. In this review, the roles of IRF4 in the immune response are briefly summarized and discussed, with particular focus on its essential and distinct functions in immune cell development.

Keywords

Interferon regulatory factor 4 (IRF4) Lymphoid cells Myeloid cells Dendritic cells (DCs) Macrophages Myeloid-derived suppressor cells (MDSCs) 

References

  1. Achuthan A, Cook AD, Lee MC, Saleh R, Khiew HW, Chang MW, Louis C, Fleetwood AJ, Lacey DC, Christensen AD, Frye AT, Lam PY, Kusano H, Nomura K, Steiner N, Forster I, Nutt SL, Olshansky M, Turner SJ, Hamilton JA (2016) Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation. J Clin Invest 126:3453–3466CrossRefPubMedGoogle Scholar
  2. Bajana S, Roach K, Turner S, Paul J, Kovats S (2012) IRF4 promotes cutaneous dendritic cell migration to lymph nodes during homeostasis and inflammation. J Immunol 189:3368–3377CrossRefPubMedPubMedCentralGoogle Scholar
  3. Barneda-Zahonero B, Roman-Gonzalez L, Collazo O, Mahmoudi T, Parra M (2012) Epigenetic regulation of B lymphocyte differentiation, transdifferentiation, and reprogramming. Comp Funct Genom 2012:564381CrossRefGoogle Scholar
  4. Becker AM, Michael DG, Satpathy AT, Sciammas R, Singh H, Bhattacharya D (2012) IRF-8 extinguishes neutrophil production and promotes dendritic cell lineage commitment in both myeloid and lymphoid mouse progenitors. Blood 119:2003–2012CrossRefPubMedPubMedCentralGoogle Scholar
  5. Brass AL, Zhu AQ, Singh H (1999) Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers. EMBO J 18:977–991CrossRefPubMedPubMedCentralGoogle Scholar
  6. Briseno CG, Haldar M, Kretzer NM, Wu X, Theisen DJ, Kc W, Durai V, Grajales-Reyes GE, Iwata A, Bagadia P, Murphy TL, Murphy KM (2016) Distinct transcriptional programs control cross-priming in classical and monocyte-derived dendritic cells. Cell Rep 15:2462–2474CrossRefPubMedGoogle Scholar
  7. Brustle A, Heink S, Huber M, Rosenplanter C, Stadelmann C, Yu P, Arpaia E, Mak TW, Kamradt T, Lohoff M (2007) The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol 8:958–966CrossRefPubMedGoogle Scholar
  8. Cretney E, Kallies A, Nutt SL (2013) Differentiation and function of Foxp3(+) effector regulatory T cells. Trends Immunol 34:74–80CrossRefPubMedGoogle Scholar
  9. El Chartouni C, Schwarzfischer L, Rehli M (2010) Interleukin-4 induced interferon regulatory factor (Irf) 4 participates in the regulation of alternative macrophage priming. Immunobiol 215:821–825CrossRefGoogle Scholar
  10. Gao Y, Nish SA, Jiang R, Hou L, Licona-Limon P, Weinstein JS, Zhao H, Medzhitov R (2013) Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity 39:722–732CrossRefPubMedPubMedCentralGoogle Scholar
  11. Gauzzi MC, Purificato C, Conti L, Adorini L, Belardelli F, Gessani S (2005) IRF-4 expression in the human myeloid lineage: up-regulation during dendritic cell differentiation and inhibition by 1alpha,25-dihydroxyvitamin D3. J Leukoc Biol 77:944–947CrossRefPubMedGoogle Scholar
  12. Grumont RJ, Gerondakis S (2000) Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB. J Exp Med 191:1281–1292CrossRefPubMedPubMedCentralGoogle Scholar
  13. Gupta S, Jiang M, Anthony A, Pernis AB (1999) Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. J Exp Med 190:1837–1848CrossRefPubMedPubMedCentralGoogle Scholar
  14. Honma K, Udono H, Kohno T, Yamamoto K, Ogawa A, Takemori T, Kumatori A, Suzuki S, Matsuyama T, Yui K (2005) Interferon regulatory factor 4 negatively regulates the production of proinflammatory cytokines by macrophages in response to LPS. Proc Natl Acad Sci USA 102:16001–16006CrossRefPubMedPubMedCentralGoogle Scholar
  15. Honma K, Kimura D, Tominaga N, Miyakoda M, Matsuyama T, Yui K (2008) Interferon regulatory factor 4 differentially regulates the production of Th2 cytokines in naive vs. effector/memory CD4+ T cells. Proc Natl Acad Sci USA 105:15890–15895CrossRefPubMedPubMedCentralGoogle Scholar
  16. Hu CM, Jang SY, Fanzo JC, Pernis AB (2002) Modulation of T cell cytokine production by interferon regulatory factor-4. J Biol Chem 277:49238–49246CrossRefPubMedGoogle Scholar
  17. Huber M, Lohoff M (2014) IRF4 at the crossroads of effector T-cell fate decision. Eur J Immunol 44:1886–1895CrossRefPubMedGoogle Scholar
  18. Huber M, Heink S, Pagenstecher A, Reinhard K, Ritter J, Visekruna A, Guralnik A, Bollig N, Jeltsch K, Heinemann C, Wittmann E, Buch T, Prazeres da Costa O, Brustle A, Brenner D, Mak TW, Mittrucker HW, Tackenberg B, Kamradt T, Lohoff M (2013) IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis. J Clin Invest 123:247–260CrossRefPubMedGoogle Scholar
  19. Hwang ES (2010) Transcriptional regulation of T helper 17 cell differentiation. Yonsei Med J 51:484–491CrossRefPubMedPubMedCentralGoogle Scholar
  20. Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, Bover L, Qin FX, Gilliet M, Liu YJ (2008) Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 28:870–880CrossRefPubMedPubMedCentralGoogle Scholar
  21. Kazimirova M, Stibraniova I (2013) Tick salivary compounds: their role in modulation of host defences and pathogen transmission. Front Cell Infect Microbiol 3:43CrossRefPubMedPubMedCentralGoogle Scholar
  22. Klein U, Casola S, Cattoretti G, Shen Q, Lia M, Mo T, Ludwig T, Rajewsky K, Dalla-Favera R (2006) Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 7:773–782CrossRefPubMedGoogle Scholar
  23. Klein M, Bruhl TJ, Staudt V, Reuter S, Grebe N, Gerlitzki B, Hoffmann M, Bohn T, Ulges A, Stergiou N, de Graaf J, Lower M, Taube C, Becker M, Hain T, Dietzen S, Stassen M, Huber M, Lohoff M, Campos Chagas A, Andersen J, Kotal J, Langhansova H, Kopecky J, Schild H, Kotsyfakis M, Schmitt E, Bopp T (2015) Tick salivary Sialostatin L represses the initiation of immune responses by targeting IRF4-dependent transcription in murine mast cells. J Immunol 195:621–631CrossRefPubMedPubMedCentralGoogle Scholar
  24. Kuwahara M, Ise W, Ochi M, Suzuki J, Kometani K, Maruyama S, Izumoto M, Matsumoto A, Takemori N, Takemori A, Shinoda K, Nakayama T, Ohara O, Yasukawa M, Sawasaki T, Kurosaki T, Yamashita M (2016) Bach2-Batf interactions control Th2-type immune response by regulating the IL-4 amplification loop. Nat Commun 7:12596CrossRefPubMedPubMedCentralGoogle Scholar
  25. Lehtonen A, Lund R, Lahesmaa R, Julkunen I, Sareneva T, Matikainen S (2003) IFN-alpha and IL-12 activate IFN regulatory factor 1 (IRF-1), IRF-4, and IRF-8 gene expression in human NK and T cells. Cytokine 24:81–90CrossRefPubMedGoogle Scholar
  26. Lehtonen A, Veckman V, Nikula T, Lahesmaa R, Kinnunen L, Matikainen S, Julkunen I (2005) Differential expression of IFN regulatory factor 4 gene in human monocyte-derived dendritic cells and macrophages. J Immunol 175:6570–6579CrossRefPubMedGoogle Scholar
  27. Li P, Spolski R, Liao W, Wang L, Murphy TL, Murphy KM, Leonard WJ (2012) BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 490:543–546CrossRefPubMedPubMedCentralGoogle Scholar
  28. Lohoff M, Mak TW (2005) Roles of interferon-regulatory factors in T-helper-cell differentiation. Nat Rev Immunol 5:125–135CrossRefPubMedGoogle Scholar
  29. Lohoff M, Mittrucker HW, Prechtl S, Bischof S, Sommer F, Kock S, Ferrick DA, Duncan GS, Gessner A, Mak TW (2002) Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc Natl Acad Sci USA 99:11808–11812CrossRefPubMedPubMedCentralGoogle Scholar
  30. Ma S, Pathak S, Trinh L, Lu R (2008) Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development. Blood 111:1396–1403CrossRefPubMedPubMedCentralGoogle Scholar
  31. Man K, Miasari M, Shi W, Xin A, Henstridge DC, Preston S, Pellegrini M, Belz GT, Smyth GK, Febbraio MA, Nutt SL, Kallies A (2013) The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells. Nat Immunol 14:1155–1165CrossRefPubMedGoogle Scholar
  32. Mangiavacchi A, Sorci M, Masciarelli S, Larivera S, Legnini I, Iosue I, Bozzoni I, Fazi F, Fatica A (2016) The miR-223 host non-coding transcript linc-223 induces IRF4 expression in acute myeloid leukemia by acting as a competing endogenous RNA. Oncotarget. doi:10.18632/oncotarget.11165 PubMedGoogle Scholar
  33. Mohapatra A, Van Dyken SJ, Schneider C, Nussbaum JC, Liang HE, Locksley RM (2016) Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis. Mucosal Immunol 9:275–286CrossRefPubMedGoogle Scholar
  34. Mudter J, Amoussina L, Schenk M, Yu J, Brustle A, Weigmann B, Atreya R, Wirtz S, Becker C, Hoffman A, Atreya I, Biesterfeld S, Galle PR, Lehr HA, Rose-John S, Mueller C, Lohoff M, Neurath MF (2008) The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6. J Clin Invest 118:2415–2426PubMedPubMedCentralGoogle Scholar
  35. Nam S, Kang K, Cha JS, Kim JW, Lee HG, Kim Y, Yang Y, Lee MS, Lim JS (2016) Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function. J Leukoc Biol. doi:10.1189/jlb.1A0215-068RR PubMedGoogle Scholar
  36. Nayar R, Enos M, Prince A, Shin H, Hemmers S, Jiang JK, Klein U, Thomas CJ, Berg LJ (2012) TCR signaling via Tec kinase ITK and interferon regulatory factor 4 (IRF4) regulates CD8+ T-cell differentiation. Proc Natl Acad Sci USA 109:E2794–E2802CrossRefPubMedPubMedCentralGoogle Scholar
  37. Nayar R, Schutten E, Bautista B, Daniels K, Prince AL, Enos M, Brehm MA, Swain SL, Welsh RM, Berg LJ (2014) Graded levels of IRF4 regulate CD8+ T cell differentiation and expansion, but not attrition, in response to acute virus infection. J Immunol 192:5881–5893CrossRefPubMedPubMedCentralGoogle Scholar
  38. Paschall AV, Zhang R, Qi CF, Bardhan K, Peng L, Lu G, Yang J, Merad M, McGaha T, Zhou G, Mellor A, Abrams SI, Morse HC 3rd, Ozato K, Xiong H, Liu K (2015) IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation. J Immunol 194:2369–2379CrossRefPubMedPubMedCentralGoogle Scholar
  39. Pathak S, Ma S, Trinh L, Lu R (2008) A role for interferon regulatory factor 4 in receptor editing. Mol Cell Biol 28:2815–2824CrossRefPubMedPubMedCentralGoogle Scholar
  40. Persson EK, Uronen-Hansson H, Semmrich M, Rivollier A, Hagerbrand K, Marsal J, Gudjonsson S, Hakansson U, Reizis B, Kotarsky K, Agace WW (2013) IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation. Immunity 38:958–969CrossRefPubMedGoogle Scholar
  41. Pongubala JM, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML (1992) PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3′ enhancer activity. Mol Cell Biol 12:368–378CrossRefPubMedPubMedCentralGoogle Scholar
  42. Porstner M, Winkelmann R, Daum P, Schmid J, Pracht K, Corte-Real J, Schreiber S, Haftmann C, Brandl A, Mashreghi MF, Gelse K, Hauke M, Wirries I, Zwick M, Roth E, Radbruch A, Wittmann J, Jack HM (2015) miR-148a promotes plasma cell differentiation and targets the germinal center transcription factors Mitf and Bach2. Eur J Immunol 45:1206–1215CrossRefPubMedGoogle Scholar
  43. Raczkowski F, Ritter J, Heesch K, Schumacher V, Guralnik A, Hocker L, Raifer H, Klein M, Bopp T, Harb H, Kesper DA, Pfefferle PI, Grusdat M, Lang PA, Mittrucker HW, Huber M (2013) The transcription factor Interferon Regulatory Factor 4 is required for the generation of protective effector CD8+ T cells. Proc Natl Acad Sci USA 110:15019–15024CrossRefPubMedPubMedCentralGoogle Scholar
  44. Rengarajan J, Mowen KA, McBride KD, Smith ED, Singh H, Glimcher LH (2002) Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J Exp Med 195:1003–1012CrossRefPubMedPubMedCentralGoogle Scholar
  45. Saito M, Gao J, Basso K, Kitagawa Y, Smith PM, Bhagat G, Pernis A, Pasqualucci L, Dalla-Favera R (2007) A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell 12:280–292CrossRefPubMedGoogle Scholar
  46. Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, Miyake T, Matsushita K, Okazaki T, Saitoh T, Honma K, Matsuyama T, Yui K, Tsujimura T, Standley DM, Nakanishi K, Nakai K, Akira S (2010) The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 11(10):936–944CrossRefPubMedGoogle Scholar
  47. Savitsky D, Tamura T, Yanai H, Taniguchi T (2010) Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol Immunother 59:489–510CrossRefPubMedGoogle Scholar
  48. Schlitzer A, McGovern N, Teo P, Zelante T, Atarashi K, Low D, Ho AW, See P, Shin A, Wasan PS, Hoeffel G, Malleret B, Heiseke A, Chew S, Jardine L, Purvis HA, Hilkens CM, Tam J, Poidinger M, Stanley ER, Krug AB, Renia L, Sivasankar B, Ng LG, Collin M, Ricciardi-Castagnoli P, Honda K, Haniffa M, Ginhoux F (2013) IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38:970–983CrossRefPubMedPubMedCentralGoogle Scholar
  49. So AY, Sookram R, Chaudhuri AA, Minisandram A, Cheng D, Xie C, Lim EL, Flores YG, Jiang S, Kim JT, Keown C, Ramakrishnan P, Baltimore D (2014) Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias. Blood 124:1502–1512CrossRefPubMedPubMedCentralGoogle Scholar
  50. Staudt V, Bothur E, Klein M, Lingnau K, Reuter S, Grebe N, Gerlitzki B, Hoffmann M, Ulges A, Taube C, Dehzad N, Becker M, Stassen M, Steinborn A, Lohoff M, Schild H, Schmitt E, Bopp T (2010) Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33:192–202CrossRefPubMedGoogle Scholar
  51. Stewart TJ, Greeneltch KM, Reid JE, Liewehr DJ, Steinberg SM, Liu K, Abrams SI (2009) Interferon regulatory factor-8 modulates the development of tumour-induced CD11b+Gr-1+ myeloid cells. J Cell Mol Med 13:3939–3950CrossRefPubMedGoogle Scholar
  52. Tamiya T, Ichiyama K, Kotani H, Fukaya T, Sekiya T, Shichita T, Honma K, Yui K, Matsuyama T, Nakao T, Fukuyama S, Inoue H, Nomura M, Yoshimura A (2013) Smad2/3 and IRF4 play a cooperative role in IL-9-producing T cell induction. J Immunol 191:2360–2371CrossRefPubMedGoogle Scholar
  53. Tamura T, Tailor P, Yamaoka K, Kong HJ, Tsujimura H, O’Shea JJ, Singh H, Ozato K (2005) IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J Immunol 174:2573–2581CrossRefPubMedGoogle Scholar
  54. Tamura T, Yanai H, Savitsky D, Taniguchi T (2008) The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 26:535–584CrossRefPubMedGoogle Scholar
  55. Tominaga N, Ohkusu-Tsukada K, Udono H, Abe R, Matsuyama T, Yui K (2003) Development of Th1 and not Th2 immune responses in mice lacking IFN-regulatory factor-4. Int Immunol 15:1–10CrossRefPubMedGoogle Scholar
  56. Tunyaplin C, Shaffer AL, Angelin-Duclos CD, Yu X, Staudt LM, Calame KL (2004) Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J Immunol 173:1158–1165CrossRefPubMedGoogle Scholar
  57. Vander Lugt B, Khan AA, Hackney JA, Agrawal S, Lesch J, Zhou M, Lee WP, Park S, Xu M, DeVoss J, Spooner CJ, Chalouni C, Delamarre L, Mellman I, Singh H (2014) Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation. Nat Immunol 15:161–167CrossRefPubMedGoogle Scholar
  58. Waight JD, Netherby C, Hensen ML, Miller A, Hu Q, Liu S, Bogner PN, Farren MR, Lee KP, Liu K, Abrams SI (2013) Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis. J Clin Invest 123:4464–4478CrossRefPubMedPubMedCentralGoogle Scholar
  59. Wang S, He Q, Ma D, Xue Y, Liu F (2015) Irf4 regulates the choice between T lymphoid-primed progenitor and myeloid lineage fates during embryogenesis. Dev Cell 34:621–631CrossRefPubMedGoogle Scholar
  60. Williams JW, Tjota MY, Clay BS, Vander Lugt B, Bandukwala HS, Hrusch CL, Decker DC, Blaine KM, Fixsen BR, Singh H, Sciammas R, Sperling AI (2013) Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation. Nat Commun 4:2990PubMedPubMedCentralGoogle Scholar
  61. Yamamoto M, Kato T, Hotta C, Nishiyama A, Kurotaki D, Yoshinari M, Takami M, Ichino M, Nakazawa M, Matsuyama T, Kamijo R, Kitagawa S, Ozato K, Tamura T (2011) Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development. PLoS ONE 6:e25812CrossRefPubMedPubMedCentralGoogle Scholar
  62. Yang C, He D, Yin C, Tan J (2015) Inhibition of interferon regulatory factor 4 suppresses Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis. Scand J Immunol 82:345–351CrossRefPubMedGoogle Scholar
  63. Yao S, Buzo BF, Pham D, Jiang L, Taparowsky EJ, Kaplan MH, Sun J (2013) Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation. Immunity 39:833–845CrossRefPubMedGoogle Scholar
  64. Zhang X, Tao Y, Troiani L, Markovic-Plese S (2011) Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis. J Immunol 187:3431–3437CrossRefPubMedGoogle Scholar
  65. Zhang Y, Shen L, Stupack DG, Bai N, Xun J, Ren G, Han J, Li L, Luo Y, Xiang R, Tan X (2016) JMJD3 promotes survival of diffuse large B-cell lymphoma subtypes via distinct mechanisms. Oncotarget 7:29387–29399PubMedPubMedCentralGoogle Scholar
  66. Zheng Y, Chaudhry A, Kas A, deRoos P, Kim JM, Chu TT, Corcoran L, Treuting P, Klein U, Rudensky AY (2009) Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458:351–356CrossRefPubMedPubMedCentralGoogle Scholar
  67. Zhu W, Jin Z, Yu J, Liang J, Yang Q, Li F, Shi X, Zhu X, Zhang X (2016) Baicalin ameliorates experimental inflammatory bowel disease through polarization of macrophages to an M2 phenotype. Int Immunopharmacol 35:119–126CrossRefPubMedGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea 2016

Authors and Affiliations

  1. 1.Department of Biological ScienceSookmyung Women’s UniversitySeoulRepublic of Korea

Personalised recommendations